URL has been copied successfully!
Skip to content
JBizNews
JBizNews
Primary Navigation Menu
Menu
  • Home
  • Breaking News
  • Top News
  • Markets
  • Crypto
  • Health
  • Real Estate
  • Events
  • Subscribe
  • About JBizNews

Health

  • April 22, 2026

    STAT+: Federal test of AI prior authorization is delaying care for seniors, report says


  • April 22, 2026

    Video: Robert F. Kennedy Jr. testifies before Senate HELP committee


  • April 22, 2026

    STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more


  • April 22, 2026

    Prices rose after No Surprises arbitration for some care: analysis


  • April 22, 2026

    Live: Robert F. Kennedy Jr. testifies before Senate HELP committee


  • April 22, 2026

    Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial


  • April 22, 2026

    Elevance perks up in 2026 though Medicare Advantage payout could ding profits


  • April 22, 2026

    Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial


  • April 22, 2026

    Elevance perks up in 2026 though Medicare Advantage payout could ding profits


  • April 22, 2026

    Amazon One Medical launches weight management program including GLP-1 drugs


  • April 22, 2026

    STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy


  • April 22, 2026

    Increased calls to 988 hotline associated with a drop in suicides among young people, study finds


  • April 22, 2026

    STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy


  • April 22, 2026

    STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more


  • April 22, 2026

    Moderna continues bird flu vax study, but limits work in the U.S.


  • April 22, 2026

    Opinion: Behind every miracle drug is a story


  • April 22, 2026

    Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush


  • April 22, 2026

    Opinion: NASA’s plans for living in space should prioritize immunology and infectious disease


  • April 22, 2026

    Opinion: The CDC’s ‘disease detective’ program turns 75


  • April 21, 2026

    STAT+: At AACR, more strong results for Revolution Medicine’s KRAS drug, plus assurance from NCI’s director


  • April 21, 2026

    STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval


  • April 21, 2026

    STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it


  • April 21, 2026

    STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom


  • April 21, 2026

    Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person


  • April 21, 2026

    STAT+: Insurers refuse to join Medicare pilot offering weight loss drugs to seniors at steep discount


  • April 21, 2026

    STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS


  • April 21, 2026

    STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS


  • April 21, 2026

    STAT+: CMS to ask every state for new audits of health care providers


  • April 21, 2026

    Opinion: STAT+: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump


  • April 21, 2026

    STAT+: RFK Jr. to face four GOP doctors at Senate hearings


  • April 21, 2026

    STAT+: UnitedHealth earnings beat expectations in the first quarter, but hurdles persist


  • April 21, 2026

    Flu vaccine no longer mandated for U.S. troops, defense secretary says


  • April 21, 2026

    QuikTrip to sell urgent care clinics after 6 years in business


  • April 21, 2026

    Providers push back on 340B rebate model


  • April 21, 2026

    Blue Shield of California taps chief pharmacy officer


  • April 21, 2026

    UnitedHealth hikes profit outlook after better-than-expected first quarter


  • April 21, 2026

    UnitedHealth Reports Strong Quarterly Turnaround, Raises Full-Year Outlook


  • April 21, 2026

    STAT+: Pharmalittle: We’re reading about a Purdue Pharma settlement, a setback for Merck and Eisai, and more


  • April 21, 2026

    STAT+: Kelonia Therapeutics’ road from floundering to $3 billion


  • April 21, 2026

    This CDC conference was always open to the public. Until now


Previous Page
1 … 40 41 42 43 44 … 50
Next Page
2026-03-30

JBIZNEWS LLC © 2026